Pharmacologic prophylaxis against venous thromboembolism in hospitalized patients with cirrhosis and associated coagulopathies

American Journal of Health-System Pharmacy

Volumn 69, Issue 8, 2012, Pages 658-663

  Koliscak, Lindsey ^a   Maynor, Lena ^b  

^a WINGATE UNIVERSITY   (United States)

^b WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

Anticoagulants; Blood coagulation disorders; Epidemiology; Hospitals; International normalized ratio; Liver cirrhosis; Venous thromboembolism

Indexed keywords

ANTICOAGULANT AGENT; FONDAPARINUX; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; SERUM ALBUMIN;

ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; CHRONIC KIDNEY DISEASE; COMORBIDITY; CONGESTIVE HEART FAILURE; DISEASE ASSOCIATION; DISEASE MARKER; HOSPITAL PATIENT; HUMAN; INTERNATIONAL NORMALIZED RATIO; LIVER CIRRHOSIS; LOW DRUG DOSE; MALNUTRITION; PRIORITY JOURNAL; RELIABILITY; RISK ASSESSMENT; RISK REDUCTION; VENOUS THROMBOEMBOLISM;

EID: 84860318470     PISSN: 10792082     EISSN: 15352900     Source Type: Journal    
DOI: 10.2146/ajhp110402     Document Type: Article

References (16)

1. Xu J, Kochanek KD, Murphy SL et al. Deaths: final data for 2007. Natl Vital Stat Rep. 2010; 58:1-5.
2. Heidelbaugh JJ, Sherbondy M. Cirrhosis and chronic liver failure: part II. Complications and treatment. Am Fam Physician. 2006; 74:767-76.
3. Northup PG. Hypercoagulation in liver disease. Clin Liver Dis. 2009; 13:109-16.
4. Tripodi A, Mannucci PM. The coagulopathy of chronic liver disease. N Engl J Med. 2011; 365:147-56.
5. Gulley D, Teal E, Suvannasankha A et al. Deep vein thrombosis and pulmonary embolism in cirrhosis patients. Dig Dis Sci. 2008; 53:3012-7.
6. Tripodi A. The coagulopathy of chronic liver disease: is there a causal relationship with bleeding? No. Eur J Intern Med. 2010; 21:65-9.
7. Gatt A, Riddell A, Calvaruso V et al. Enhanced thrombin generation in patients with cirrhosis-induced coagulopathy. J Thromb Haemost. 2010; 8:1994-2000.
8. Northup PG, McMahon MM, Ruhl AP et al. Coagulopathy does not fully protect hospitalized cirrhosis patients from peripheral venous thromboembolism. Am J Gastroenterol. 2006; 101:1524-8. (Pubitemid 43980626)
9. Dabbagh O, Oza A, Prakash S et al. Coagulopathy does not protect against venous thromboembolism in hospitalized patients with chronic liver disease. Chest. 2010; 137:1145-9.
10. Ali M, Ananthakrishnan AN, McGinley EL et al. Deep vein thrombosis and pulmonary embolism in hospitalized patients with cirrhosis: a nationwide analysis. Dig Dis Sci. 2011; 56:2152-9.
11. Tripodi A, Salerno F, Chantarangkul V et al. Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests. Hepatology. 2005; 41:553-8. (Pubitemid 40289502)
12. Senzolo M, Sartori MT, Lisman T. Should we give thromboprophylaxis to patients with liver cirrhosis and coagulopathy? HBP (Oxford). 2009; 11:459-64.
13. Søgaard KK, Horváth-Puhó E, Grøbæk H et al. Risk of venous thromboembolism in patients with liver disease: a nationwide population-based case-control study. Am J Gastroenterol . 2009; 104:96-101.
14. Geerts WH, Bergqvist D, Pineo GF et al. Prevention of venous thromboembolism: American College of Chest Physicians evidence-based clinical practice guidelines (8th ed.). Chest . 2008; 133:381S-453S. (Pubitemid 351894916)
15. Wu H, Nguyen GC. Liver cirrhosis is associated with venous thromboembolism among hospitalized patients in a nationwide US study. Clin Gastroenterol Hepatol. 2010; 8:800-5.
16. Aldawood A, Arabi Y, Alijumah A et al. The incidence of venous thromboembolism and practice of deep venous thrombosis prophylaxis in hospitalized cirrhotic patients. Thromb J. 2011; 9:1-6.